Avita Medical hires Erin Liberto as CCO
Medical device company Avita Medical has named Erin Liberto as the company’s chief commercial officer.
Liberto will have responsibility for successful execution of the company’s comprehensive commercial strategy including the further development of the company’s sales, reimbursement and marketing efforts, and will report directly to CEO Dr Michael Perry.
“Erin’s extensive experience in the global dermatology markets, including a proven track record of successful US product launches, will be instrumental as we position ReCell in the US burns market following our anticipated PMA approval next year,” said Dr Perry.
“We are laying the foundation for our future growth across multiple indications, and I’m energised to be working with Erin as we continue to leverage our clinical progress across a broad range of indications.”
Liberto was most recently VP of marketing, Topical Dermatology at Allergan where she led the commercial operations of marketing and strategic communication for two dermatology franchises: SkinMedica, a cash-pay, physician-dispensed topical aesthetics business unit and the Medical Dermatology division, which included reimbursed topical pharmaceutical products for skin conditions and where she oversaw more than US$650 m of business revenue.
Oxytocin analogue treats chronic abdominal pain
Researchers have developed a new class of oral painkillers to suppress chronic abdominal pain,...
'Low-risk' antibiotic linked to rise of dangerous superbug
A new study has challenged the long-held belief that rifaximin — commonly prescribed to...
Robotic hand helps cultivate baby corals for reef restoration
The soft robotic hand could revolutionise the delicate, labour-intensive process of cultivating...
